Transfusion management of beta (β) thalassemia : What to transfuse: specifications for red blood cell products : a thalassemia resource for healthcare providers
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i

Transfusion management of beta (β) thalassemia : What to transfuse: specifications for red blood cell products : a thalassemia resource for healthcare providers

Filetype[PDF-391.78 KB]


English
Details You May Also Like

Details:

  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
  • Description:
    Healthcare providers can work with their blood bank partners to develop thalassemia-specific red blood cell transfusion protocols. In selecting red blood cell (RBC) products for patients receiving regular transfusions, it’s important for the clinical team to carefully consider which products emphasize efficacy (hemoglobin response) while also minimizing risk of hemolytic and non-hemolytic transfusion complications.

    Reference: Lal A, Wong T, Keel S, Pagano M, Chung J, Kamdar A, et al. The transfusion management of beta thalassemia in the United States. Transfusion. 2021;1–13. https://onlinelibrary.wiley.com/doi/10.1111/trf.16640

    The Thalassemia Transfusion Resources were supported by cooperative agreement number CDC-RFA-DD19-1903, funded by the Centers for Disease Control and Prevention (CDC). They were developed by Georgia State University Research Foundation, Inc., Joan & Sanford I. Weill Medical College of Cornell University, and The Regents of the University of California San Francisco in collaboration with CDC. The materials have been developed as a supplemental (user-friendly) resource for healthcare providers, blood banks, and persons with thalassemia and their families to provide key information from a recent evidence-based report that details recommendations for the transfusion management of beta thalassemia in the United States.

    CS 340845-A June 15, 2023

    transfusion-management-of-beta-thalassemia.pdf

  • Subjects:
  • Document Type:
    Pamphlet (or booklet)
  • Funding:
    cooperative agreement number CDC-RFA-DD19-1903
  • Genre:
    Fact Sheet
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

  • No Additional Files
More +

You May Also Like

Checkout today's featured content at stacks.cdc.gov